Prasad Sandhir B, Guppy-Coles Kristyan B, Holland David, Stanton Tony, Krishnasamy Rathika, Whalley Gillian, Atherton John J, Thomas Liza
Department of Cardiology, Royal Brisbane and Women's Hospital, Butterfield Street, Herston, Brisbane, Queensland, Australia.
Department of Cardiology, Sunshine Coast University Hospital, 6 Doherty Street, Birtinya, Queensland, Australia.
Int J Cardiol Heart Vasc. 2019 Aug 3;24:100407. doi: 10.1016/j.ijcha.2019.100407. eCollection 2019 Sep.
Recent data suggests that the majority of cardiac deaths in patients with heart failure occur in patients with a left ventricular ejection fraction (LVEF) >35%. This study sought to determine the value of guideline based assessment of diastolic dysfunction in predicting all-cause mortality in patients with a first-ever myocardial infarction (MI) with an LVEF >35%.
A retrospective single centre study involving 383 patients with a first-ever MI (STEMI or NSTEMI) with LVEF >35% was performed. Clinical, angiographic and echocardiographic data were obtained from prospectively maintained institutional databases. Outcomes data were obtained from national death registry. Echocardiography was performed early post-admission for all patients. Significant diastolic dysfunction (DD) was defined was grade 2/3 diastolic dysfunction according to current American Society of Echocardiography/European Association of Cardiovascular Imaging guidelines.
At a median follow up of 2 years, there were 32 deaths. On Cox proportional hazards multivariate analysis incorporating significant clinical variables (age, chronic kidney disease and extent of coronary artery disease), significant DD (HR 2.57, 95%CI 1.16-5.68, = 0.020) and left ventricular end-diastolic volume index (HR 1.03, 1.04-1.07, = 0.021) were the only independent echocardiographic predictors of all-cause mortality. Intermodel comparisons using model χ and Harrel's-C confirmed incremental value of DD. In the subgroup with LVEF 36-55% ( = 176), significant DD was the only independent echocardiographic predictor (HR 3.56, 95%CI 2.46-9.09, = 0.006).
The presence of significant DD identifies patients with LVEF >35% following MI who are at a higher risk of all-cause mortality, and who may benefit from further risk stratification and treatment.
近期数据表明,心力衰竭患者中大多数心脏死亡发生在左心室射血分数(LVEF)>35%的患者中。本研究旨在确定基于指南的舒张功能障碍评估在预测首次心肌梗死(MI)且LVEF>35%患者的全因死亡率方面的价值。
进行了一项回顾性单中心研究,纳入383例首次发生MI(ST段抬高型心肌梗死或非ST段抬高型心肌梗死)且LVEF>35%的患者。从前瞻性维护的机构数据库中获取临床、血管造影和超声心动图数据。结局数据从国家死亡登记处获取。所有患者在入院后早期进行超声心动图检查。根据当前美国超声心动图学会/欧洲心血管影像协会指南,显著舒张功能障碍(DD)定义为2/3级舒张功能障碍。
在中位随访2年时,有32例死亡。在纳入显著临床变量(年龄、慢性肾病和冠状动脉疾病程度)的Cox比例风险多变量分析中,显著DD(风险比2.57,95%置信区间1.16 - 5.68,P = 0.020)和左心室舒张末期容积指数(风险比1.03,1.04 - 1.07,P = 0.021)是全因死亡率仅有的独立超声心动图预测因素。使用模型χ和Harrel's-C进行的模型间比较证实了DD的增量价值。在LVEF为36 - 55%的亚组(n =